105 related articles for article (PubMed ID: 22989032)
1. Insights into the novel hydrolytic mechanism of a diethyl 2-phenyl-2-(2-arylacetoxy)methyl malonate ester-based microsomal triglyceride transfer protein (MTP) inhibitor.
Ryder T; Walker GS; Goosen TC; Ruggeri RB; Conn EL; Rocke BN; Lapham K; Steppan CM; Hepworth D; Kalgutkar AS
Chem Res Toxicol; 2012 Oct; 25(10):2138-52. PubMed ID: 22989032
[TBL] [Abstract][Full Text] [Related]
2. Pharmacological characterization of diethyl-2-({3-dimethylcarbamoyl-4-[(4'-trifluoromethylbiphenyl-2-carbonyl)amino]phenyl}acetyloxymethyl)-2-phenylmalonate (JTT-130), an intestine-specific inhibitor of microsomal triglyceride transfer protein.
Mera Y; Odani N; Kawai T; Hata T; Suzuki M; Hagiwara A; Katsushima T; Kakutani M
J Pharmacol Exp Ther; 2011 Feb; 336(2):321-7. PubMed ID: 20974698
[TBL] [Abstract][Full Text] [Related]
3. JTT-130, a novel intestine-specific inhibitor of microsomal triglyceride transfer protein, suppresses food intake and gastric emptying with the elevation of plasma peptide YY and glucagon-like peptide-1 in a dietary fat-dependent manner.
Hata T; Mera Y; Ishii Y; Tadaki H; Tomimoto D; Kuroki Y; Kawai T; Ohta T; Kakutani M
J Pharmacol Exp Ther; 2011 Mar; 336(3):850-6. PubMed ID: 21139060
[TBL] [Abstract][Full Text] [Related]
4. JTT-130, a novel intestine-specific inhibitor of microsomal triglyceride transfer protein, ameliorates lipid metabolism and attenuates atherosclerosis in hyperlipidemic animal models.
Mera Y; Kawai T; Ogawa N; Odani N; Sasase T; Miyajima K; Ohta T; Kakutani M
J Pharmacol Sci; 2015 Nov; 129(3):169-76. PubMed ID: 26598005
[TBL] [Abstract][Full Text] [Related]
5. A small-molecule inhibitor of enterocytic microsomal triglyceride transfer protein, SLx-4090: biochemical, pharmacodynamic, pharmacokinetic, and safety profile.
Kim E; Campbell S; Schueller O; Wong E; Cole B; Kuo J; Ellis J; Ferkany J; Sweetnam P
J Pharmacol Exp Ther; 2011 Jun; 337(3):775-85. PubMed ID: 21406547
[TBL] [Abstract][Full Text] [Related]
6. JTT-130, a novel intestine-specific inhibitor of microsomal triglyceride transfer protein, suppresses high fat diet-induced obesity and glucose intolerance in Sprague-Dawley rats.
Hata T; Mera Y; Tadaki H; Kuroki Y; Kawai T; Ohta T; Kakutani M
Diabetes Obes Metab; 2011 May; 13(5):446-54. PubMed ID: 21255216
[TBL] [Abstract][Full Text] [Related]
7. Mechanism of action of hypoglycemic effects of an intestine-specific inhibitor of microsomal triglyceride transfer protein (MTP) in obese rats.
Sakata S; Katsumi S; Mera Y; Kuroki Y; Nashida R; Kakutani M; Ohta T
J Pharmacol Sci; 2015 Jan; 127(1):103-8. PubMed ID: 25704025
[TBL] [Abstract][Full Text] [Related]
8. JTT-130, a novel intestine-specific inhibitor of microsomal triglyceride transfer protein, reduces food preference for fat.
Mera Y; Hata T; Ishii Y; Tomimoto D; Kawai T; Ohta T; Kakutani M
J Diabetes Res; 2014; 2014():583752. PubMed ID: 24959597
[TBL] [Abstract][Full Text] [Related]
9. A rational chemical intervention strategy to circumvent bioactivation liabilities associated with a nonpeptidyl thrombopoietin receptor agonist containing a 2-amino-4-arylthiazole motif.
Kalgutkar AS; Driscoll J; Zhao SX; Walker GS; Shepard RM; Soglia JR; Atherton J; Yu L; Mutlib AE; Munchhof MJ; Reiter LA; Jones CS; Doty JL; Trevena KA; Shaffer CL; Ripp SL
Chem Res Toxicol; 2007 Dec; 20(12):1954-65. PubMed ID: 17935300
[TBL] [Abstract][Full Text] [Related]
10. Discovery of microsomal triglyceride transfer protein (MTP) inhibitors with potential for decreased active metabolite load compared to dirlotapide.
Robinson RP; Bartlett JA; Bertinato P; Bessire AJ; Cosgrove J; Foley PM; Manion TB; Minich ML; Ramos B; Reese MR; Schmahai TJ; Swick AG; Tess DA; Vaz A; Wolford A
Bioorg Med Chem Lett; 2011 Jul; 21(14):4150-4. PubMed ID: 21684740
[TBL] [Abstract][Full Text] [Related]
11. JTT-130, a novel intestine-specific inhibitor of microsomal triglyceride transfer protein, ameliorates impaired glucose and lipid metabolism in Zucker diabetic fatty rats.
Hata T; Mera Y; Kawai T; Ishii Y; Kuroki Y; Kakimoto K; Ohta T; Kakutani M
Diabetes Obes Metab; 2011 Jul; 13(7):629-38. PubMed ID: 21362121
[TBL] [Abstract][Full Text] [Related]
12. Inhibition of microsomal triglyceride transfer protein: another mechanism for drug-induced steatosis in mice.
Lettéron P; Sutton A; Mansouri A; Fromenty B; Pessayre D
Hepatology; 2003 Jul; 38(1):133-40. PubMed ID: 12829995
[TBL] [Abstract][Full Text] [Related]
13. Metabolism and bioactivation of 3-methylindole by human liver microsomes.
Yan Z; Easterwood LM; Maher N; Torres R; Huebert N; Yost GS
Chem Res Toxicol; 2007 Jan; 20(1):140-8. PubMed ID: 17226936
[TBL] [Abstract][Full Text] [Related]
14. Oleate-mediated stimulation of microsomal triglyceride transfer protein (MTP) gene promoter: implications for hepatic MTP overexpression in insulin resistance.
Qiu W; Taghibiglou C; Avramoglu RK; Van Iderstine SC; Naples M; Ashrafpour H; Mhapsekar S; Sato R; Adeli K
Biochemistry; 2005 Mar; 44(8):3041-9. PubMed ID: 15723548
[TBL] [Abstract][Full Text] [Related]
15. NADPH-dependent covalent binding of [3H]paroxetine to human liver microsomes and S-9 fractions: identification of an electrophilic quinone metabolite of paroxetine.
Zhao SX; Dalvie DK; Kelly JM; Soglia JR; Frederick KS; Smith EB; Obach RS; Kalgutkar AS
Chem Res Toxicol; 2007 Nov; 20(11):1649-57. PubMed ID: 17907785
[TBL] [Abstract][Full Text] [Related]
16. Isozyme-selective metabolism of ethyl carbamate by cytochrome P450 (CYP2E1) and carboxylesterase (hydrolase A) enzymes in murine liver microsomes.
Lee RP; Parkinson A; Forkert PG
Drug Metab Dispos; 1998 Jan; 26(1):60-5. PubMed ID: 9443854
[TBL] [Abstract][Full Text] [Related]
17. Bioactivation of the tricyclic antidepressant amitriptyline and its metabolite nortriptyline to arene oxide intermediates in human liver microsomes and recombinant P450s.
Wen B; Ma L; Zhu M
Chem Biol Interact; 2008 May; 173(1):59-67. PubMed ID: 18359012
[TBL] [Abstract][Full Text] [Related]
18. Bioactivation of isothiazoles: minimizing the risk of potential toxicity in drug discovery.
Teffera Y; Choquette D; Liu J; Colletti AE; Hollis LS; Lin MH; Zhao Z
Chem Res Toxicol; 2010 Nov; 23(11):1743-52. PubMed ID: 20825217
[TBL] [Abstract][Full Text] [Related]
19. NTP technical report on the toxicity studies of Dibutyl Phthalate (CAS No. 84-74-2) Administered in Feed to F344/N Rats and B6C3F1 Mice.
Marsman D
Toxic Rep Ser; 1995 Apr; 30():1-G5. PubMed ID: 12209194
[TBL] [Abstract][Full Text] [Related]
20. JTT-130, a novel intestine-specific inhibitor of microsomal triglyceride transfer protein, improves hyperglycemia and dyslipidemia independent of suppression of food intake in diabetic rats.
Sakata S; Ito M; Mera Y; Sasase T; Yamamoto H; Kakutani M; Ohta T
J Diabetes Res; 2014; 2014():803832. PubMed ID: 24895641
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
